Concepedia

Anna Fettiplace

AF

3

Publications

484

Citations

3

H-Index

2016

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Anna Fettiplace is an author at GlaxoSmithKline (United Kingdom) specializing in clinical trials, hiv/aids counselling, and aids pathogenesis.

Top concepts

HivMedicineVirologyPharmacologyPublic HealthClinical TrialsPharmacotherapyAids PathogenesisHiv/aids CounsellingClinical Epidemiology

Publications per year

2016–2024

3

Publications

3

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 371 citations · Full text

Hiv/aids Counselling, Treatment And Prevention, Week 48 +14

Psychiatric Symptoms in Patients Receiving Dolutegravir

Anna Fettiplace, Chris Stainsby, Alan Winston et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 99 citations · Full text

Consensus Guidelines: Best Practices for the Prevention, Detection and Management of Hepatitis B Virus Reactivation in Clinical Trials with Immunosuppressive/Immunomodulatory Therapy

E. Cohen, Arie Regev, Anju Garg et al. · Drug Safety · 2024 · 14 citations · Full text

Rows per page

1–3 of 3